Friess Associates’s Axogen AXGN Stock Holding History

Friess Associates’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.08M	Sell	253,546 -168,105	-40%	-$1.44M	3.47%	13
2022 Q1	$3.35M	Buy	421,651 +162,573	+63%	+$1.4M	1.79%	15
2021 Q4	$2.43M	Sell	259,078 -8,498	-3%	-$102K	0.95%	47
2021 Q3	$4.23M	Buy	267,576 +8,702	+3%	+$156K	1.78%	20
2021 Q2	$5.59M	Buy	+258,874	New	+$5.23M	2.11%	15
2019 Q3	–	Sell	-574,802	Closed	-$11.4M	–	111
2019 Q2	$11.4M	Buy	574,802 +164,544	+40%	+$3.52M	0.83%	54
2019 Q1	$8.64M	Buy	+410,258	New	+$7.49M	0.63%	60
2018 Q4	–	Sell	-100,000	Closed	-$3.69M	–	118
2018 Q3	$3.69M	Buy	100,000 +70,000	+233%	+$3.06M	0.26%	83
2018 Q2	$1.51M	Buy	+30,000	New	+$1.32M	0.12%	102
2017 Q4	–	Sell	-5,199	Closed	-$101K	–	106
2017 Q3	$101K	Sell	5,199 -143,423	-97%	-$2.41M	0.01%	96
2017 Q2	$2.49M	Sell	148,622 -25,228	-15%	-$340K	0.23%	83
2017 Q1	$1.82M	Buy	+173,850	New	+$1.77M	0.17%	85

Other funds holding AXGN

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Friess Associates's AXGN Position: Q2 2022 in Review

Friess Associates reduced its Axogen (AXGN) stake by 40% in Q2 2022, selling an estimated $1.44M and leaving 253,546 shares worth $2.08M. The position accounts for 3.47% of the portfolio, ranked #13.

Friess Associates first reported a position in AXGN in Q1 2017 and has held it in 12 quarters since. The position peaked at $11.4M in Q2 2019. 113 funds tracked by Wall St. Rank hold AXGN as of Q2 2022.

Friess Associates held 253,546 shares of Axogen worth $2.08M as of Q2 2022.
Friess Associates sold 168,105 Axogen shares in Q2 2022, an estimated $1.44M.
Axogen made up 3.47% of Friess Associates's portfolio in Q2 2022, its #13 holding.
Friess Associates first reported a position in Axogen in Q1 2017 and has held it in 12 quarters since.
Friess Associates's Axogen position peaked at $11.4M in Q2 2019.
113 funds tracked by Wall St. Rank held Axogen as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.